retatrutide safety profile Efficacy and of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials Retatrutide—A Game Changer in Obesity

Theyre older, and they became severely dehydrated and experienced an exacerbation of their atrial fibrillation [irregular heart rhythm]

Member satisfaction is a leading indicator in measuring overall quality of care and patient engagement

Those promoting Ozempic for cosmetic weight loss claim that it offers a fast, no-frills option for slimming down

Consumers should be wary of dietary supplements claiming to contain GLP-1 or promising "GLP-1-like" effects, as these claims are not FDA-approved and lack scientific validity

Semaglutide also showed benefits for those with heart failure and kidney disease

In some instances, publicly available data or prior years survey responses were used obtain information on Medicaid programs in these states